View in EDS

1502P CaboRISE (AIO-HEP-0320/ass.): A phase II study evaluating reduced starting dose and dose escalation of cabozantinib as second-line therapy for advanced HCC in patients with preserved liver function.

Saved in:
Bibliographic Details
Title: 1502P CaboRISE (AIO-HEP-0320/ass.): A phase II study evaluating reduced starting dose and dose escalation of cabozantinib as second-line therapy for advanced HCC in patients with preserved liver function.
Authors: Koch, C.1 (AUTHOR), Waldschmidt, D.T.2 (AUTHOR), Goetze, T.O.3 (AUTHOR), Ehmer, U.4 (AUTHOR), Ertl, S.5 (AUTHOR), Schmidt, H.6 (AUTHOR), Van Bömmel, F.7 (AUTHOR), Jacobasch, L.8 (AUTHOR), Pink, D.9 (AUTHOR), Wehler, T.C.10 (AUTHOR), Roderburg, C.11 (AUTHOR), Angermeier, S.12 (AUTHOR), Al-Batran, S-E.3 (AUTHOR), Brulin, T.13 (AUTHOR), Trojan, J.1 (AUTHOR)
Source: Annals of Oncology. 2025 Supplement 2, Vol. 36, pS901-S901. 1p.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 189419925
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: 1502P CaboRISE (AIO-HEP-0320/ass.): A phase II study evaluating reduced starting dose and dose escalation of cabozantinib as second-line therapy for advanced HCC in patients with preserved liver function.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Koch%2C+C%2E%22">Koch, C.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Waldschmidt%2C+D%2ET%2E%22">Waldschmidt, D.T.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Goetze%2C+T%2EO%2E%22">Goetze, T.O.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ehmer%2C+U%2E%22">Ehmer, U.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ertl%2C+S%2E%22">Ertl, S.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Schmidt%2C+H%2E%22">Schmidt, H.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Van+Bömmel%2C+F%2E%22">Van Bömmel, F.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Jacobasch%2C+L%2E%22">Jacobasch, L.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Pink%2C+D%2E%22">Pink, D.</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wehler%2C+T%2EC%2E%22">Wehler, T.C.</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Roderburg%2C+C%2E%22">Roderburg, C.</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Angermeier%2C+S%2E%22">Angermeier, S.</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Al-Batran%2C+S-E%2E%22">Al-Batran, S-E.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Brulin%2C+T%2E%22">Brulin, T.</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Trojan%2C+J%2E%22">Trojan, J.</searchLink><relatesTo>1</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2025 Supplement 2, Vol. 36, pS901-S901. 1p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=189419925
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.annonc.2025.08.2132
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 1
        StartPage: S901
    Titles:
      – TitleFull: 1502P CaboRISE (AIO-HEP-0320/ass.): A phase II study evaluating reduced starting dose and dose escalation of cabozantinib as second-line therapy for advanced HCC in patients with preserved liver function.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Koch, C.
      – PersonEntity:
          Name:
            NameFull: Waldschmidt, D.T.
      – PersonEntity:
          Name:
            NameFull: Goetze, T.O.
      – PersonEntity:
          Name:
            NameFull: Ehmer, U.
      – PersonEntity:
          Name:
            NameFull: Ertl, S.
      – PersonEntity:
          Name:
            NameFull: Schmidt, H.
      – PersonEntity:
          Name:
            NameFull: Van Bömmel, F.
      – PersonEntity:
          Name:
            NameFull: Jacobasch, L.
      – PersonEntity:
          Name:
            NameFull: Pink, D.
      – PersonEntity:
          Name:
            NameFull: Wehler, T.C.
      – PersonEntity:
          Name:
            NameFull: Roderburg, C.
      – PersonEntity:
          Name:
            NameFull: Angermeier, S.
      – PersonEntity:
          Name:
            NameFull: Al-Batran, S-E.
      – PersonEntity:
          Name:
            NameFull: Brulin, T.
      – PersonEntity:
          Name:
            NameFull: Trojan, J.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 09
              Text: 2025 Supplement 2
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 09237534
          Numbering:
            – Type: volume
              Value: 36
          Titles:
            – TitleFull: Annals of Oncology
              Type: main
ResultId 1